Aceragen, Inc. Last Day of Trading - EIN Presswire - EIN News
ACGNDelisted Stock | 0.75 0.23 23.47% |
About 62% of Aceragen's investor base is looking to short. The analysis of current outlook of investing in Aceragen suggests that many traders are alarmed regarding Aceragen's prospects. Aceragen's investing sentiment overview a quick insight into current market opportunities from investing in Aceragen. Many technical investors use Aceragen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aceragen |
Aceragen, Inc. Last Day of Trading - EIN Presswire EIN News
Read at news.google.com
Aceragen Fundamental Analysis
We analyze Aceragen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aceragen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aceragen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Aceragen is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Aceragen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aceragen stock to make a market-neutral strategy. Peer analysis of Aceragen could also be used in its relative valuation, which is a method of valuing Aceragen by comparing valuation metrics with similar companies.
Peers
Aceragen Related Equities
SNTI | Senti Biosciences | 362.96 | ||||
AKTX | Akari Therapeutics | 12.40 | ||||
QNRX | Quoin Pharmaceuticals | 6.67 | ||||
SNGX | Soligenix | 0.90 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
TPST | Tempest Therapeutics | 1.04 | ||||
ACRV | Acrivon Therapeutics, | 1.85 | ||||
COCP | Cocrystal Pharma | 1.90 | ||||
SABS | SAB Biotherapeutics | 3.77 | ||||
BPTH | Bio Path | 3.90 | ||||
ADXN | Addex Therapeutics | 4.02 | ||||
ARMP | Armata Pharmaceuticals | 4.35 | ||||
IBIO | Ibio | 4.76 | ||||
RNXT | RenovoRx | 5.51 | ||||
PCSA | Processa Pharmaceuticals | 7.76 | ||||
ATXI | Avenue Therapeutics | 9.77 | ||||
ACXP | Acurx Pharmaceuticals | 10.40 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Aceragen Stock
If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data |